Cargando…

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study

BACKGROUND: Oral corticosteroids are important components of pharmacotherapy in severe asthma. Our objective was to describe the extent, trends, and factors associated with exposure to oral corticosteroids (OCS) in a severe asthma cohort. METHODS: We used administrative health databases of British C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadatsafavi, Mohsen, Khakban, Amir, Tavakoli, Hamid, Ehteshami-Afshar, Solmaz, Lynd, Larry D., FitzGerald, J. Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034163/ https://www.ncbi.nlm.nih.gov/pubmed/33836765 http://dx.doi.org/10.1186/s12931-021-01696-x

Ejemplares similares

Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study
por: Khakban, Amir, et al.
Publicado: (2019)

Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study
por: Tavakoli, Hamid, et al.
Publicado: (2018)

The impact of comorbidities on productivity loss in asthma patients
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2016)

Post-hospital syndrome in adults with asthma: a case-crossover study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2013)

Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2012)

Correction: Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2013)

Complementary and alternative asthma treatments and their association with asthma control: a population-based study
por: Chen, Wenjia, et al.
Publicado: (2013)

Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
por: Chen, Wenjia, et al.
Publicado: (2021)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada
por: Tavakoli, Hamid, et al.
Publicado: (2019)

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
por: Zafari, Zafar, et al.
Publicado: (2016)

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial
por: De Vera, Mary A, et al.
Publicado: (2014)

Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
por: Najafzadeh, Mehdi, et al.
Publicado: (2012)

Antibiotic consumption in children prior to diagnosis of asthma
por: Marra, Fawziah, et al.
Publicado: (2011)

Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada
por: Ng, Bryan, et al.
Publicado: (2019)

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations
por: Sadatsafavi, Mohsen, et al.
Publicado: (2014)

Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
por: Chen, Wenjia, et al.
Publicado: (2023)

Economic burden of asthma: a systematic review
por: Bahadori, Katayoun, et al.
Publicado: (2009)

A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases
por: Safari, Abdollah, et al.
Publicado: (2023)

Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study
por: Raymakers, AJN, et al.
Publicado: (2020)

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality
por: Kendzerska, Tetyana, et al.
Publicado: (2017)

Oral Corticosteroids Tapering in Severe Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2021)

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
por: Sadatsafavi, Mohsen, et al.
Publicado: (2018)

Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
por: Amegadzie, Joseph E., et al.
Publicado: (2023)

Is Certolizumab Pegol Safe and Effective in the Treatment of Patients with Moderate to Severe Crohn’s Disease? A Meta-analysis of Controlled Clinical Trials
por: Nikfar, Shekoufeh, et al.
Publicado: (2013)

COVID-19 mRNA Vaccines and Interstitial Lung Disease Exacerbation: Causation or Just a Temporal Association?
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2022)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Asthma guidelines: Global to local
por: FitzGerald, J. Mark
Publicado: (2009)

Trends and predictors of specialist assessments in oral corticosteroid treated asthma among young adults
por: Skov, Inge Raadal, et al.
Publicado: (2022)

Prevalence of oral corticosteroid use in the German severe asthma population
por: Taube, Christian, et al.
Publicado: (2019)

The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
por: Yaghoubi, Mohsen, et al.
Publicado: (2019)

Malignant hyperthermia in severe COVID-19: 2 case reports
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2021)

Achieving asthma control: Providing a framework for clinicians
por: FitzGerald, J. Mark
Publicado: (2016)

A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2011)

Current recommendations for the treatment of mild asthma
por: Shahidi, Neal, et al.
Publicado: (2010)

Long-Term Natural History of Severe Asthma Exacerbations and Their Impact on the Disease Course
por: Lee, Tae Yoon, et al.
Publicado: (2022)

The role of asthma guidelines in achieving current control and reducing future risk
por: FitzGerald, J. Mark
Publicado: (2012)

Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype
por: Knarborg, Malene, et al.
Publicado: (2014)

Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_htko41s3j5j8eev9u4a04tohjj